* Apollo Medical Holdings Inc AMEH.OQ AMEH.O is expected
to show a fall in quarterly revenue when it reports results on
November 4.
* The Alhambra, California-based company is expected to report
a 1.2% decrease in revenue to $178.001 million from $180.12
million a year ago, according to the estimate from one analyst,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Apollo Medical Holdings
Inc is for earnings of 34 cents per share. For the same quarter
last year, the company reported earnings of 45 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Apollo Medical
Holdings Inc is $91, about 21.5% above its last closing price
of $71.45.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Jun. 30 2021 0.21 0.21 0.28 Beat 33.3
Mar. 31 2021 0.22 0.22 0.30 Beat 36.4
Dec. 31 2020 0.18 0.18 0.27 Beat 50
Sep. 30 2020 0.22 0.22 0.45 Beat 104.5
Jun. 0.07 0.07 -1.75 Missed -2,600
30 2020
Mar. 31 2020 0.04 0.04 0.11 Beat 175
Dec. 31 2019 0.20 0.18 Missed -10
Sep. 30 2019 0.14 0.14 0.10 Missed -28.6
This summary was machine generated November 3 at 13:39 GMT. All
figures in US dollars unless otherwise stated